Edition:
United Kingdom

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

1.97USD
19 Sep 2018
Change (% chg)

$0.07 (+3.68%)
Prev Close
$1.90
Open
$1.82
Day's High
$2.04
Day's Low
$1.82
Volume
27,340
Avg. Vol
33,081
52-wk High
$7.68
52-wk Low
$1.80

Chart for

About

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $56.67
Shares Outstanding(Mil.): 23.51
Dividend: --
Yield (%): --

Financials

  SNSS.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.94 -- --
ROI: -174.35 1.78 14.61
ROE: -- 3.27 16.33

BRIEF-Sunesis Pharmaceuticals Qtrly Loss Per Share $0.21

* SUNESIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

08 May 2018

Competitors

Earnings vs. Estimates